New cancer clinical trial: K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor

Published on: April 09, 2018 at 12:00PM
Conditions:   PD-L1 Positive Mutation Tumor;   EBV Positive Mutation Tumor;   MSI-H Mutation Tumor;   POLE/POLD1 Mutation Tumor
Intervention:   Drug: Avelumab
Sponsor:   Yonsei University
Recruiting
https://ift.tt/2qn65K3